Abiopharma

News list

Director McEwan Duncan J 🟡 adjusted position in 0 shares (1 derivative) of Sphere 3D Corp. (ANY) Transaction Date: Jun 01, 2026 | Filing ID: 003001

Full text

News bot June 2, 2026, 11:11 p.m.
🔍 McEwan Duncan J (Director)

Company: Sphere 3D Corp. (ANY)

Report Date: 2026-06-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 74,074
- Total shares sold: 74,074
Detailed Transactions and Holdings:
- Acquired 74,074 shares of Common Shares (Direct)
  Date: 2026-06-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 74,074.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 74,074 shares of Restricted Stock Unit (RSU) (Derivative)
  Date: 2026-06-01 | Code: M | Expires: 2026-06-01 | Exercise: 2026-06-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1
Footnotes:
- F1: Each RSU represents a contingent right to receive one common share of Sphere 3D Corp.